Please login to the form below

Not currently logged in

Amgen finance VP joins True North Therapeutics

Pamela Wapnick appointed as chief financial officer

California-based True North Therapeutics has appointed Pamela Wapnick as its new chief financial officer.

Wapnick joins the rare diseases clinical stage biopharmaceutical company from Amgen, where she most recently served as vice president of finance.

Prior to this, Wapnick had corporate finance responsibility for Amgen's global research and development activities, and has served as vice president and treasurer of Amgen.

She brings over 25 years of international business and finance experience to True North, including senior financial management positions at Delphi Corporation, Federal Mogul Corporation and General Motors Corporation.

Nancy Stagliano, chief executive officer of True North, said: “I am pleased to announce Pam's appointment to the position of chief financial officer as a member of our management team.

“Her breadth of experience in corporate finance and treasury within the biotechnology industry, including nearly 10 years and Amgen, will serve us well as we continue to advance True North's pipeline of novel product candidates.”

3rd August 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....